Goldman Sachs’s EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share EQHA.WS Stock Holding History

Goldman Sachs's EQHA.WS Position: Q4 2022 in Review

Goldman Sachs sold out of EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share (EQHA.WS) in Q4 2022, closing a stake of 135,001 shares — an estimated $9K sold.

Goldman Sachs first reported a position in EQHA.WS in Q1 2021 and held it in 7 quarters. The position peaked at $96K in Q2 2021. 1 fund tracked by Wall St. Rank holds EQHA.WS as of Q4 2022.

• Goldman Sachs reported no remaining EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q4 2022 after selling out during the quarter.
• Goldman Sachs sold 135,001 EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q4 2022, an estimated $9K.
• Goldman Sachs first reported a position in EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q1 2021 and held it in 7 quarters.
• Goldman Sachs's EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $96K in Q2 2021.
• 1 fund tracked by Wall St. Rank held EQ Health Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q4 2022.

Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.